Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3

26 Feb 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Endoplasmic Reticulum Stress and Disease
Share to Lipid metabolism and disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29483174
DOI: 10.1161/circulationaha.117.031335

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3PMID 29483174Read ↗

Treatment of Dyslipidemia Using CRISPR/Cas9 Genome EditingSemantic proximity Read ↗

Gene-based therapy in lipid management: the winding road from promise to practiceSemantic proximity Read ↗

In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primatesSemantic proximity Read ↗

Liver-specific in vivo base editing of Angptl3 via AAV delivery efficiently lowers blood lipid levels in miceSemantic proximity Read ↗

CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulationSemantic proximity Read ↗

How ANGPTL3 Inhibition Will Help Our Clinical Practice?Semantic proximity Read ↗

Gene editing in common cardiovascular diseasesSemantic proximity Read ↗

Genetics: ANGPTL3 deficiency protects from CAD.Semantic proximity Read ↗

Advances in nucleic acid-targeted therapies for cardiovascular disease preventionSemantic proximity Read ↗

The Genetic Revolution in Cardiometabolic Disease: A Review of Novel RNA and Gene‐Editing Therapies Targeting APOC3, ANGPTL3, and Lp(a)Semantic proximity Read ↗

Weekly journal scan: a new small-interfering RNA to fight a genetic cardiovascular risk factor.Semantic proximity Read ↗

Base Editing Gene Therapy for Heterozygous Familial HypercholesterolemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.